文献速递血脂与心血管预防心力衰竭与心肌病心律失常

英格兰癌症诊断时心血管疾病负担的时间趋势

Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England.
PubMed 文献 · Eur Heart J · 2026-08-31

结果显示年龄标准化患病率从2001-2005年的31.4%升至2016-2020年的39.2%,瓣膜病、心衰、房颤和糖尿病亚型增幅最大;若当前趋势持续,到2050年约半数癌症患者诊断时可能已有CVD。

要点

  • 癌症诊断时已存在CVD的年龄标准化患病率从31.4%升至39.2%。
  • 肺癌和血液系统癌症的CVD患病率增幅最陡。
  • 瓣膜病、心衰、房颤和糖尿病是亚型中上升最大的。

核心结论

  • 癌症诊断时已存在CVD在20年间大幅增加,预测到2050年将影响近半数患者。
  • 这些趋势强调需要扩展心脏肿瘤学服务。

研究设计与样本

  • 采用系列横断面分析估计已存在CVD及合并症的年度粗患病率和年龄标准化患病率。
  • 使用调整人口学和癌症类型的逻辑回归评估时间趋势,序贯模型评估风险因素领域的贡献,人口学调整样条模型预测至2050年。

主要发现

  • 已存在CVD的年龄标准化患病率从2001-2005年的31.4%(95%CI 31.2-31.6)升至2016-2020年的39.2%(95%CI 39.0-39.4)。
  • 肺癌和血液系统癌症的增幅最陡。
  • 瓣膜病、心衰、房颤和糖尿病显示最大的亚型上升。
  • 调整心血管代谢疾病和慢性合并症后,时间趋势的衰减最大。
  • 预测分析提示若当前时间模式持续,到2050年约半数患者癌症诊断时可能已有CVD。

临床怎么用

  • 心脏肿瘤学服务需扩展以应对癌症诊断时日益增加的心血管合并症负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Advances in cancer care have improved survival, increasing the importance of comorbidities at diagnosis for longer-term outcomes. Pre-existing cardiovascular disease (CVD) can complicate management and prognosis, yet its long-term trends and future burden at cancer diagnosis are unclear. This study aimed to quantify temporal trends in pre-existing CVD among patients with newly diagnosed cancer and project prevalence through 2050. METHODS: Linked primary care, cancer registry, and hospitalization records were used to identify 773 590 adults (≥18 years) diagnosed with the five most common cancers between 2001 and 2020 in England. Serial cross-sectional analyses estimated annual crude and age-standardized prevalence of pre-existing CVD and comorbidities. Temporal trends were assessed using logistic regression adjusted for demographics and cancer type. The contributions of changes in risk factor domains were evaluated using sequential modelling, and CVD prevalence was projected to 2050 using demographic-adjusted spline models. RESULTS: The age-standardized prevalence of pre-existing CVD rose from 31.4% [95% confidence interval (CI) 31.2-31.6] in 2001-2005 to 39.2% (95% CI 39.0-39.4) in 2016-2020, with the steepest increases in lung and haematological cancers. Valvular disease, heart failure, atrial fibrillation, and diabetes showed the largest subtype rises. Sequential modelling showed the greatest attenuation of the temporal trend after adjustment for cardiometabolic conditions and chronic comorbidities. Projection analyses suggest that, if current temporal patterns continue, approximately half of patients may present with pre-existing CVD at cancer diagnosis by 2050. CONCLUSIONS: Pre-existing CVD at cancer diagnosis has increased substantially over 2 decades and is projected to affect nearly half of patients by 2050. These trends underscore the need for the expansion of cardio-oncology services.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Alshahrani AA, Kontopantelis E, Morgan C, et al. Cardiovascular disease burden at cancer diagnosis: temporal trends in a national study from England. Eur Heart J. 2026. PMID: 42669566. doi:10.1093/eurheartj/ehag626

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。